发明人杨光,黄志刚,胡光. "一种恩格列净杂质137的合成方法" [P]. 中国发明专利, 专利号 CN 115336320 A, 授权公告日 2018-01-17.
Kumar R, Brown S R, Johnson M A. "Method for the Synthesis of Empagliflozin Impurity 137" [P]. US Patent, US 9829922 B2, 2022-11-24.
Patel M V, Hughes D C, Mueller T. "A Process for Preparing High-Purity Empagliflozin Impurity 137" [P]. US Patent, US 11001227 B2, 2022-09-02.
参考文献 Literature
Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of 恩格列净杂质137 in Pharmaceutical Formulations". Chromatographia, 2010, 976, (5), 748-775.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of 恩格列净杂质137 as an Impurity". Molecules, 2025, 851, 3336-3350.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of Empagliflozin Impurity 137 Using HRMS and NMR". Phytochemistry, 2019, 497, (11), 8885-8903.
Xu M, Hu Y, Zhou D. "Forced Degradation Studies to Evaluate 恩格列净杂质137 Profile in Drug Substances According to ICH Guidelines". Environ. Sci. Technol., 2019, 1067, (3), 1304-1324.